Susan Devlin

Executive Director at Novelion Therapeutics - , ,

Susan Devlin's Colleagues at Novelion Therapeutics
Roger Louis

Acting Head Research & Development

Contact Roger Louis

Weger, Mary

Chief Performance Officer

Contact Weger, Mary

Eileen Rogers

Director of Patient Services

Contact Eileen Rogers

Craig Quinn

Senior Director Market Access

Contact Craig Quinn

Iris Cheong

Associate Director of Finance

Contact Iris Cheong

View All Susan Devlin's Colleagues
Susan Devlin's Contact Details
HQ
N/A
Location
Company
Novelion Therapeutics
Susan Devlin's Company Details
Novelion Therapeutics logo, Novelion Therapeutics contact details

Novelion Therapeutics

, , • 250 - 499 Employees
Other

Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc. (Aegerion), which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.

N/A
Details about Novelion Therapeutics
Frequently Asked Questions about Susan Devlin
Susan Devlin currently works for Novelion Therapeutics.
Susan Devlin's role at Novelion Therapeutics is Executive Director.
Susan Devlin's email address is ***@novelion.com. To view Susan Devlin's full email address, please signup to ConnectPlex.
Susan Devlin works in the Biotechnology industry.
Susan Devlin's colleagues at Novelion Therapeutics are Roger Louis, Weger, Mary, Eileen Rogers, Michael Colacino, Craig Quinn, Iris Cheong and others.
Susan Devlin's phone number is N/A
See more information about Susan Devlin